REGULATION OF EARLY T-CELL DEVELOPMENT BY THE ENGAGEMENT OF TCR-BETA COMPLEX EXPRESSED ON FETAL THYMOCYTES FROM TCR-BETA-TRANSGENIC SCID MICE

被引:0
|
作者
TAKAHAMA, Y [1 ]
SUGAYA, K [1 ]
TSUDA, S [1 ]
HASEGAWA, T [1 ]
HASHIMOTO, Y [1 ]
机构
[1] SYNTEX, INST IMMUNOL, NIIHARI, IBARAKI, JAPAN
来源
JOURNAL OF IMMUNOLOGY | 1995年 / 154卷 / 11期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transgenic expression of the beta-chain of T cell antigen-receptor (TCR) is known to induce the generation of CD4(+)CD8(+) thymocytes in the immunodeficient scid mouse, in which thymocyte development is otherwise arrested at CD4(-)CD8(-) cells. It is not clear, however, whether or not the thymocyte development is controlled by ligand engagement of the TCR-beta complex on the cell surface. In the present study, we have examined how the engagement by Ab of the TCR-beta complex expressed on the TCR-beta-transgenic scid fetal thymocytes can regulate the generation of CD4(+)CD8(+) thymocytes. Organ cultures of CD4(-)CD8(-) day 14 fetal thymocytes from the TCR-beta-transgenic scid mice resulted in the generation of CD4(-)CD8(+) and then CD4(+)CD8(+) cells. The initial step from CD4(-)CD8(-) cells to CD4(-)CD(8)+ cells was enhanced by the addition of anti-TCR-beta Ab, whereas the subsequent step from CD4(-)CD8(+) cells to CD4(+)CD8(+) cells was markedly inhibited by anti-TCR-beta Ab. These results indicate that ligand engagement of the TCR-beta complex can positively and negatively regulate the early thymocyte development. Moreover, the finding that engagement of TCR-beta complex inhibits the generation of CD4(+)CD8(+) cells suggests that the induction of CD4(+)CD8(+) thymocytes by the TCR-beta transgene is not an immediate consequence of cell-surface engagement of the TCR-beta complex but requires liberation from the continued TCR-beta signaling.
引用
收藏
页码:5862 / 5869
页数:8
相关论文
共 50 条
  • [31] CHARACTERIZATION OF A PRETHYMIC PRECURSOR OF THE T-CELL BEARING A TRANSGENIC V-BETA-8.2 TCR
    SMITH, RT
    LINCOLN, GC
    SHENG, BD
    FASEB JOURNAL, 1994, 8 (05): : A785 - A785
  • [32] TCR beta-independent development of CD4(+) CD8(+) thymocytes observed in a strain of scid mice
    Shibata, S
    Asano, T
    Ogura, A
    Hashimoto, N
    Hayakawa, J
    Naiki, M
    Doi, K
    IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (02): : 154 - 160
  • [33] AUTOIMMUNITY OCCURS IN TRANSGENIC T-CELL RECEPTOR (TCR) BETA-GENE NON-OBESE DIABETIC (NOD) MICE
    LIPES, MA
    FENTON, RG
    ZHOU, LJ
    SEIDMAN, JG
    EISENBARTH, GS
    CLINICAL RESEARCH, 1989, 37 (02): : A572 - A572
  • [34] TCR-ALPHA/BETA MODULATION, APOPTOSIS AND PERIPHERAL T-CELL DELETION IN NORMAL AND BCL-2 TRANSGENIC MICE
    HUANG, L
    CRISPE, IN
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 445 - 445
  • [35] Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas
    S M Rodríguez-Pinilla
    M E C Sánchez
    J Rodríguez
    J F García
    B Sánchez-Espiridión
    L F Lamana
    G Sosa
    J C Rivero
    J Menárguez
    I B Gómez
    F I Camacho
    P R Guillen
    C P S Orduña
    G Rodríguez
    C Barrionuevo
    R Franco
    M Mollejo
    J F Marco
    R D de Otazu
    M A Piris
    Blood Cancer Journal, 2013, 3 : e111 - e111
  • [36] Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas
    Rodriguez-Pinilla, S. M.
    Sanchez, M. E. C.
    Rodriguez, J.
    Garcia, J. F.
    Sanchez-Espiridion, B.
    Lamana, L. F.
    Sosa, G.
    Rivero, J. C.
    Menarguez, J.
    Gomez, I. B.
    Camacho, F. I.
    Guillen, P. R.
    Orduna, C. P. S.
    Rodriguez, G.
    Barrionuevo, C.
    Franco, R.
    Mollejo, M.
    Marco, J. F.
    de Otazu, R. D.
    Piris, M. A.
    BLOOD CANCER JOURNAL, 2013, 3 : e111 - e111
  • [37] BLOCKAGE OF ALPHA-BETA T-CELL DEVELOPMENT BY TCR GAMMA-DELTA TRANSGENES
    BONNEVILLE, M
    ISHIDA, I
    MOMBAERTS, P
    KATSUKI, M
    VERBEEK, S
    BERNS, A
    TONEGAWA, S
    NATURE, 1989, 342 (6252) : 931 - 934
  • [38] Th2 T-cell clones from TCR transgenic mice are diabetogenic.
    He, Jing
    Haskins, Kathryn
    CLINICAL IMMUNOLOGY, 2006, 119 : S173 - S174
  • [39] Unimpaired clearance of Mycobacterium bovis BCG infection in selectively T-cell anergic TCR-V beta 8.2 transgenic mice
    Koide, Y
    Yoshida, A
    Uchijima, M
    Yoshida, TO
    IMMUNOLOGY, 1995, 86 (04) : 499 - 505
  • [40] Development and characterization of human T-cell receptor (TCR) alpha and beta clones' library as biological standards and resources for TCR sequencing and engineering
    Wei, Yu-Chun
    Pospiech, Mateusz
    Meng, Yiting
    Alachkar, Houda
    BIOLOGY METHODS & PROTOCOLS, 2024, 9 (01):